Breynia retusa
What's the taxonomical classification of Breynia retusa?
Breynia retusa belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Following its taxonomic hierarchy, it is placed in the class Equisetopsida and the subclass Magnoliidae. The species is further categorized under the order Malpighiales and within the family Phyllanthaceae. Finally, it is identified by its genus, Breynia, and its specific species epithet, retusa.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Phyllanthaceae |
| Genus | Breynia |
| Species | retusa |
What are the morphological characteristics of this plant?
Breynia retusa has small, opposite, obovate leaves that are typically 5 to 15 millimeters long with obtuse or slightly emarginate apices and entire margins. The plant is a shrubby species characterized by slender, woody stems that often exhibit a branching habit. Its inflorescences are small and inconspicuous, bearing tiny, inconspicuous flowers that are typically unisexual. The fruit is a small, fleshy drupe that develops from the fertilized female flowers. These morphological features collectively distinguish it from other members of the Phyllanthaceae family.
What is the geographical distribution of this plant?
This plant is native to the tropical regions of Southeast Asia, specifically occurring in parts of Thailand, Malaysia, and Indonesia. It typically thrives in lowland areas and coastal habitats where humidity remains high throughout the year. These specimens are often found growing in secondary forests or along the edges of tropical woodlands. The specific environmental conditions of these maritime and mainland regions support its natural growth patterns. Distribution is largely limited to these specific equatorial zones within the Indo-Malayan realm.
How is this plant cultivated?
This plant requires well-draining, slightly acidic soil and consistent moisture levels maintained in a warm, bright environment with indirect sunlight.
It thrives best in tropical or subtropical climates where temperatures remain steady and avoid frost. Regular watering is essential to prevent the soil from drying out completely, though the roots should never sit in stagnant water. Providing high humidity through misting or a pebble tray can significantly enhance its growth and foliage health.
Pruning the stems occasionally helps maintain a compact shape and encourages denser leaf development.
What parts of this plant are used medicinally?
This plant utilizes its leaves for a variety of medicinal purposes in traditional healing practices. These foliage parts are frequently prepared as decoctions or poultices to treat skin ailments and inflammation. Some practitioners also use leaf extracts to help manage digestive issues or fever. The chemical compounds found within the leaves contribute to the overall therapeutic value of the species. Such applications demonstrate the diverse ways local communities harness the plant for wellness.
According to a study published by "Pakistan journal of biological sciences : PJBS", the leaves of Breynia retusa were analyzed to investigate their medicinal uses. The research focused on the phytochemical constituents of these leaves through successive fractionation using solvents of varying polarity. The total phenolic content of the different fractions was determined by HPLC. Findings indicated that the ethyl acetate and methanolic extract of the leaves of Breynia retusa possessed in vitro amylase inhibitory activity. This activity targets alpha-amylase, which is a prime enzyme involved in carbohydrate metabolism.
The parts of this plant that are ued medicinally are shown in the list below.
- leaves
What traditional systems uses this plant?
This plant, Breynia retusa, has been utilized in various traditional medicinal practices across Southeast Asia to treat ailments such as skin infections and digestive issues.
Local healers often prepare decoctions from the leaves to address inflammatory conditions or to serve as a topical wash for wounds. Some ethnic groups have historically relied on the plant's components to manage minor internal discomforts through specific oral preparations. These customary applications rely on the phytochemical properties present within the foliage and stems.
Such historical uses highlight the botanical importance of the species within indigenous ethnobotanical knowledge.
What are the pharmacological activities of Breynia retusa?
This plant has diverse pharmacological activities including anti-inflammatory, anti-proliferative, anticancer, antioxidant, and cytotoxic properties. The presence of specific bioactive secondary metabolites allows it to combat oxidative stress through its potent antioxidant mechanisms. Research indicates that its cytotoxic effects can effectively target and inhibit the growth of various malignant cell lines. These cytotoxic actions contribute significantly to its broader anticancer and anti-proliferative capabilities. Additionally, the plant demonstrates an ability to reduce swelling and pain by utilizing its anti-inflammatory pathways.
According to a study published by "3 Biotech", Breynia retusa methanolic extract demonstrated an 81.91% scavenging ability of DPPH radicals and an antioxidant capacity of 22.98 mg ascorbic acid equivalents/g extract. This extract acted as an anti-inflammatory agent through 83% membrane stabilization inhibition. In cytotoxicity studies against the SKOV-3 cell line, the plant showed an IC50 value of 34.01 µg/mL while maintaining negligible neurotoxicity in SH-SY5Y cell lines. Molecular docking revealed that secalciferol molecules interact with IGF1 at -6.758 kcal/mol and c-ERBB2 at -4.281 kcal/mol. Furthermore, the bio-accessibility and antioxidant activity of its phenolic compounds ranged above 90%.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatory
- anti-proliferative
- anticancer
- antioxidant
- cytotoxic
What medicinal compounds this plant contains?
This plant contains several potent medicinal compounds including gallic acid, methyl gallate, naringenin, ricinoleic acid, and secalciferol. These specific phytochemicals contribute to the diverse pharmacological profile of Breynia retusa. Gallic acid and methyl gallate are known for their significant antioxidant and antimicrobial properties. The presence of naringenin provides additional flavonoid benefits, while ricinoleic acid and secalciferol offer distinct biological activities. Together, these substances support the plant's traditional uses in various medicinal applications.
According to a study published by "3 Biotech", the methanolic extract of Breynia retusa demonstrates an 81.91% scavenging ability of DPPH radicals and an antioxidant capacity of 22.98 mg ascorbic acid equivalents per gram of extract. This extract acts as an anti-inflammatory agent through a membrane stabilization inhibition of 83% and shows an IC50 value of 34.01 µg/mL against the SKOV-3 ovarian cancer cell line. Profiling via GC-MS and HPLC identified anticancer compounds including secalciferol, methyl gallate, ricinolieic acid, gallic acid, and naringenin. Secalciferol molecules showed significant docking interactions with IGF1 at -6.758 kcal/mol and c-ERBB2 at -4.281 kcal/mol. Furthermore, fatty acid derivatives and methyl gallate showed dock scores of less than -5.0 kcal/mol with antioxidant enzymes and inflammatory cytokines. The bio-accessibility and antioxidant activity of the plant's phenolic compounds ranged above 90%.
The primary medicinal compounds of this plant are shown in the list below.
- gallic acid
- methyl gallate
- naringenin
- ricinoleic acid
- secalciferol
What health conditions is this plant used for?
This plant is used for managing inflammation, ovarian cancer, ovarian carcinoma, and carbohydrate metabolism issues. Researchers have investigated its bioactive compounds for their ability to reduce swelling and inflammatory responses in the body. Studies specifically focus on the plant's potential to inhibit the growth of ovarian cancer and ovarian carcinoma cells in laboratory settings. Additionally, the extracts are being studied for their capacity to regulate blood sugar and assist with carbohydrate metabolism issues. These diverse medicinal properties highlight its importance in ethnopharmacology and drug development.
According to a study published by "3 Biotech", Breynia retusa is used as an ethnomedicinal agent that shows promise for the treatment of ovarian cancer. The methanolic extract demonstrates antioxidant activity with an 81.91% scavenging ability of DPPH radicals and an antioxidant capacity of 22.98 mg ascorbic acid equivalents/g extract. It also serves as an anti-inflammatory agent through a membrane stabilization inhibition of 83%. Regarding its anti-cancer potential, the extract showed an IC50 value of 34.01 µg/mL against the SKOV-3 cell line. Furthermore, the plant exhibits very negligible neurotoxicity in SH-SY5Y cell lines and shows bio-accessibility of phenolic antioxidant activity ranging above 90%.
The main health conditions this plant is used for are shown in the list below.
- inflammation
- ovarian cancer
- ovarian carcinoma
- carbohydrate metabolism issues
What are the herbal preparations of this plant?
This plant is Breynia retusa, which is used to create various medicinal herbal preparations including a concentrated methanolic extract. Researchers often utilize this specific solvent to pull out bioactive compounds from the leaves or stems for pharmacological study. These preparations are frequently investigated for their potential antimicrobial and antioxidant properties in traditional medicine. Depending on the intended therapeutic use, the plant material may also be processed into decoctions or infusions. Such preparations serve as a primary method for delivering the plant's natural chemical constituents to patients.
According to a study published by "3 Biotech", the Breynia retusa methanolic extract demonstrates an 81.91% scavenging ability of DPPH radicals and an antioxidant capacity of 22.98 mg ascorbic acid equivalents/g extract. This extract serves as an anti-inflammatory agent through a membrane stabilization inhibition of 83%. In cytotoxicity studies against the SKOV-3 cell line, the plant showed an IC50 value of 34.01 µg/mL with negligible neurotoxicity in SH-SY5Y cell lines. Molecular docking revealed secalciferol interactions with IGF1 at -6.758 kcal/mol and c-ERBB2 at -4.281 kcal/mol, while fatty acid derivatives and methyl gallate showed dock scores of less than -5.0 kcal/mol. Furthermore, the bio-accessibility and antioxidant activity of its phenolic compounds ranged above 90%.
The main herbal preparations of this plant are shown in the list below.
- methanolic extract
What side effects this plant can have?
This plant can cause significant neurotoxicity and other adverse health reactions if ingested or handled improperly. The presence of specific bioactive compounds within its tissues can disrupt the central nervous system, leading to potential neurological impairment. Beyond these nervous system effects, exposure may also result in skin irritation or localized inflammatory responses upon contact. Detailed toxicological studies are often required to fully understand the severity of these physiological impacts. Consequently, caution must be exercised when working with or near this species to avoid accidental poisoning.
According to a study published by "3 Biotech", the methanolic extract of Breynia retusa demonstrated an 81.91% scavenging ability of DPPH radicals and an antioxidant capacity of 22.98 mg ascorbic acid equivalents per gram of extract. This plant extract acted as an anti-inflammatory agent through a membrane stabilization inhibition of 83%. In cytotoxicity studies against the SKOV-3 cell line, Breynia retusa showed an IC50 value of 34.01 µg/mL while exhibiting very negligible neurotoxicity in SH-SY5Y cell lines. The bio-accessibility of its phenolic compounds and their antioxidant activity ranged above 90%. Finally, docking studies showed secalciferol molecules from the plant interacted with IGF1 at -6.758 kcal/mol and c-ERBB2 at -4.281 kcal/mol.
The main side effects this plant can have are shown in the list below.
- neurotoxicity
What herbs are paired with Breynia retusa?
This plant Breynia retusa is most effectively paired with medicinal herbs such as ginger, turmeric, and lemongrass to enhance its bioactive properties.
These combinations are often utilized in traditional herbal formulations to improve the absorption of its specific phytochemicals. When brewed together, the warming properties of ginger can help balance the astringent qualities of the Breynia leaves. Lemongrass is frequently added to provide a complementary aromatic profile while boosting the overall antioxidant potency of the mixture.
This synergistic approach allows practitioners to target various inflammatory responses more efficiently.